Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA commissioner-designate

This article was originally published in The Tan Sheet

Executive Summary

Jane Henney, MD, expected to be sworn into office following the Nov. 3 general elections. Henney may report to work by the end of November, at the earliest. FDA Associate Commissioner for Strategic Management Linda Suydam is heading up the transition team until Henney starts. While Henney's confirmation will inevitably lead to changes at the top agency level, it may not have much of an effect on center-level management. The ceremony is likely to take place at the White House
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS089019

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel